FDA Shelves Emergency Authorization for Blood Plasma COVID-19 Treatment
Citing the absence of strong data showing effectiveness, the United States Food and Drug Administration (FDA) decided to wait on issuing an emergency authorization for a blood plasma treatment for COVID-19. The treatment involves…